1'-acetoxychavicol acetate has been researched along with pyrazines in 1 studies
| Studies (1'-acetoxychavicol acetate) | Trials (1'-acetoxychavicol acetate) | Recent Studies (post-2010) (1'-acetoxychavicol acetate) | Studies (pyrazines) | Trials (pyrazines) | Recent Studies (post-2010) (pyrazines) |
|---|---|---|---|---|---|
| 83 | 0 | 35 | 12,165 | 1,373 | 5,747 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, Y; Iida, S; Kimura, Y; Kizaki, M; Nemoto-Anan, T; Ri, M; Sagawa, M; Tabayashi, T; Tokuhira, M; Tomikawa, T; Watanabe, R | 1 |
1 other study(ies) available for 1'-acetoxychavicol acetate and pyrazines
| Article | Year |
|---|---|
TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities.
Topics: Antineoplastic Agents; Apoptosis; bcl-X Protein; Benzyl Alcohols; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; G1 Phase Cell Cycle Checkpoints; Humans; Janus Kinase 2; Multiple Myeloma; Myeloid Cell Leukemia Sequence 1 Protein; NF-kappa B; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Quantitative Structure-Activity Relationship; STAT3 Transcription Factor | 2015 |